Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions
Justification for type of information:
A structural analogue substance was used for assessment since the performed study is well documented, according to current guidelines and GLP compliant. The "Structural Analogues Substances Approach" is provided in chapter 13.2.
Cross-reference
Reason / purpose for cross-reference:
read-across: supporting information

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1974
Report date:
1974

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Cytogenetic study to determe chromosomal damage: This is accomplished
by observing cells in anaphase. As the chromatids separate and move along the spindle, aberrations may occur.
GLP compliance:
not specified
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
Silicic acid, aluminum sodium salt
EC Number:
215-684-8
EC Name:
Silicic acid, aluminum sodium salt
Cas Number:
1344-00-9
Molecular formula:
nSiO2*mAl2O3*zNa2O n = 2-4; m = 0.12-3.20; z = 0.11-4.5
IUPAC Name:
Silicic acid, aluminium sodium salt
Test material form:
solid: nanoform, no surface treatment
Specific details on test material used for the study:
Sodium aluminosilicate (Compound FDA 71-45, Synthetic Silica, Lot Number SR-1621, as supplied by the Food and Drug Administration)

Method

Species / strain
Species / strain / cell type:
mammalian cell line, other: human embryonic lung cultures (WI-38)
Metabolic activation:
without
Test concentrations with justification for top dose:
1, 10, 100 µg/ml
Vehicle / solvent:
saline
Controls
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
triethylenemelamine

Results and discussion

Test results
Key result
Species / strain:
mammalian cell line, other: human embryonic lung cultures (WI-38)
Metabolic activation:
without
Genotoxicity:
not determined
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Positive controls validity:
valid
Additional information on results:
The negative controls, medium level and low level tested exhibited 2, 0, and 1 percent acentric fragments, respectively. The high level had one cell with an acentric fragment and one cell with a bridge. This was not considered significant. The positive controls contained four cells with pulverization together with other aberrations.

Applicant's summary and conclusion

Conclusions:
The compound produced no significant aberration in the anaphase chromosomes of human tissue culture cells when tested at the dosage levels employed in this study.
Executive summary:

This study investigated into the potential of Sodium aluminosilicate to produce cytotoxicity in human embryonic lung cultures (WI-38). No significant changes to the control were observed.